Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/09/2001US6300492 Nucleotide sequences for the prevention of suppression of apoptosis and treatment lymphoma, leukemia, melanoma, ovarian, mammary gland, pancreatic and lung cancers
10/09/2001US6300490 Expression vector coding cytosine deaminase; for use in the treatment of cancers
10/09/2001US6300489 Small and cysteine rich antifungal defensin and thionine-like protein genes highly expressed in the incompatible interaction
10/09/2001US6300488 Modified lepidopteran receptors and hybrid multifunctional proteins for use in transcription and regulation of transgene expression
10/09/2001US6300485 Myosin IXa and cyclic nucleotide gated channel-15 (CNGC-15) polynucleotides, polypeptides, compositions, methods, and uses thereof
10/09/2001US6300484 DNA encoding DP. 75 and a process for its use
10/09/2001US6300482 MDKI, a novel receptor tyrosine kinase
10/09/2001US6300479 Immunoglobulins; for use in diagnosis and treatment of cancer
10/09/2001US6300478 Polyclonal antibody; for treating cancer, viral infections and bacterial infections
10/09/2001US6300477 Preferential immunoglobulin; for use in treatment of arthritis; for prevention of bacterial and viral infection; for use in gene therapy
10/09/2001US6300476 Anti-peptide antibody against human cytochrome P450 3A4
10/09/2001US6300475 Interferon PRO655
10/09/2001US6300474 Modified interferons
10/09/2001US6300473 SLM-1: a novel Sam68-like mammalian protein
10/09/2001US6300471 FSH-releasing peptides
10/09/2001US6300470 Amino acid sequence for the treatment of inflammatory pathology; microbiocides
10/09/2001US6300364 For decreasing low density lipoprotein cholesterol level
10/09/2001US6300320 Modulation of c-jun using inhibitors of protein kinase C
10/09/2001US6300317 Eukarotic cells, polynucleotide, functional agents, membrane permeability, subcellar localization agents and polynucleotide masking agents
10/09/2001US6300312 Prostaglandin receptor antagonist binding to intracellular molecular interfaces
10/09/2001US6300310 Amino acid sequence with segments of polypeptides
10/09/2001US6300139 FTCD antigen
10/09/2001US6300134 RNA transformation vectors derived from a single-component RNA virus and contain an intervening sequence between the cap and the 5′ end
10/09/2001US6300133 RNA transformation vectors derived from an uncapped single-component RNA virus
10/09/2001US6300129 Transgenic non-human animals for producing heterologous antibodies
10/09/2001US6300127 Bone mineralization proteins, DNA, vectors, expression systems
10/09/2001US6300118 Plasmids comprising a genetically altered feline immunodeficiency virus genome
10/09/2001US6300112 β-xylosidase, nucleotide sequence encoding it, and use thereof
10/09/2001US6300110 A recombinant peptide for regulating telomere length and modulating telomerase activity; detection, diagnosis and therapy of cellular proliferative diseases, cancer and aging
10/09/2001US6300103 A protein isolated from sugar beets; fungicides, viricides, herbicide resistance, nematode resistance, bacteriocides
10/09/2001US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins
10/09/2001US6300101 An outer surface protein; diagnosis of lyme disease; vaccines
10/09/2001US6300100 Process for preparing tissue factor pathway inhibitor
10/09/2001US6300099 Methods for producing secreted ligand-binding fusion proteins
10/09/2001US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders
10/09/2001US6300094 Polynucleotides encoding a novel ABC transporter
10/09/2001US6300093 Islet cell antigen 1851
10/09/2001US6300089 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/09/2001US6300087 A screening method to determine drugs that bind to human serotonin receptors by exposing nonneuronal cells expressing the serotonin receptor on their surface with a plurality of drugs; determine which drugs interact by binding
10/09/2001US6300086 Transform cells with polynucleotides encoding ligand protein and domain proteins with a reporter gene whose expression is regulated by ligands binding the domain protein; culture cells with/without agent, measure expression based on binding
10/09/2001US6300085 Diagnostic method for Alzheimer's disease
10/09/2001US6300084 Anti-mitotic agent screening process
10/09/2001US6300083 Assaying D-amino acids in body fluids
10/09/2001US6300080 Screening molecular libraries to identify lead drug compounds that modulate adhesion between lymphocytes and cadherin expressing cells by performing adhesion assays with and without one molecular library member and compare results
10/09/2001US6300074 Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
10/09/2001US6300067 TFIIB transcription factor from Candida albicans and methods of screening for inhibitors of Candida albicans growth
10/09/2001US6300064 Protein/(poly)peptide libraries
10/09/2001US6300062 Enamel matrix related polypeptide
10/09/2001US6300061 Screening drug susceptibilities of mycobacterial lysogens by using a luciferase reporter mycobacteriophage incubated with clinical samples, expressing the reporter gene if the sample contains the mycobacteria, diagnosing mycobacterial infection
10/09/2001US6300059 Testing tissue sample to determime the expression levels of mrna or protein encoded by a p53 mediator, waf1, and compare values to normal tissue; diagnosis and therapy of human tumors, cancer therapy
10/09/2001US6299880 Cell surface protein compounds
10/09/2001US6299879 Methods of immunization by administering fibrinogen binding protein or fragments thereof
10/09/2001US6299877 Used in therapy
10/09/2001US6299876 Cytotoxic drug therapy
10/09/2001US6299870 Has antiviral activity, antitumor activity, growth inhibition activity and immunosupressive activity; used in therapy
10/09/2001US6299869 Human interferon-epsilon: a type I interferon
10/09/2001US6299067 Bar code scanner with intuitive head aiming and collimated scan volume
10/09/2001CA2179656C Chromosomal expression of heterologous genes in bacterial cells
10/09/2001CA2123223C Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/09/2001CA1341302C Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
10/09/2001CA1341300C Recombinant dna means and method for producing bovine rennin and precursors
10/07/2001CA2342961A1 Immunoassay for lsd and 2-oxo-3-hydroxy-lsd
10/05/2001CA2340300A1 Nucleotide sequences that code for the rplk gene and methods of use thereof
10/04/2001WO2001073444A2 Receptor/peptide crystal structure for identification of inhibitors
10/04/2001WO2001073436A1 SOLUTION AND CRYSTAL STRUCTURES OF ZipA AND ZipA COMPLEX AND USES THEREOF
10/04/2001WO2001073130A1 Diagnostic polymorphisms of tgf-beta1 promoter
10/04/2001WO2001073107A1 Prion-free transgenic ungulates
10/04/2001WO2001073089A1 Control of aerial branching
10/04/2001WO2001073088A1 Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds
10/04/2001WO2001073087A1 Cestrum yellow leaf curling virus promoters
10/04/2001WO2001073086A2 Method for genetically modifying a plant
10/04/2001WO2001073083A2 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use
10/04/2001WO2001073081A1 Escherichia coli strain secreting human granulocyte colony stimulating factor (g-csf)
10/04/2001WO2001073080A2 Recombinant iron uptake proteins
10/04/2001WO2001073078A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide
10/04/2001WO2001073076A2 Helicase inhibitors
10/04/2001WO2001073072A1 Novel polypeptide--- a human molecular chaperone 18 and polynucleotide encoding it
10/04/2001WO2001073070A1 Novel polypeptide--- a rjs related protein 94 and polynucleotide encoding it
10/04/2001WO2001073069A1 Novel polypeptide-a human tumor related nucleoprotein 12 and polynucleotide encoding it
10/04/2001WO2001073068A1 Novel polypeptide - a line 1-12 and polynucleotide encoding it
10/04/2001WO2001073067A1 Novel polypeptide --- a human formin protein 12 and polynucleotide encoding it
10/04/2001WO2001073064A1 Novel polypeptide, a microtubulin helper factor 9 and polynucleotide encoding it
10/04/2001WO2001073062A1 Novel polypeptide--- a prostate specific membrane antigen 18 and polynucleotide encoding it
10/04/2001WO2001073061A1 Novel polypeptide - a human retinoblastoma protein 22 and polynucleotide encoding it
10/04/2001WO2001073040A1 Clostridium difficile polypeptides and uses thereof
10/04/2001WO2001073039A1 Mutants of lactobacillus casei defective in carbon catabolism regulation
10/04/2001WO2001073038A2 Method for the biotechnological production of l-alaninol
10/04/2001WO2001073037A2 R5 protein, a cell-surface protective antigen of group b streptococci
10/04/2001WO2001073036A1 Gene concerning brassinosteroid-sensitivity of plants and utilization thereof
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073031A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/04/2001WO2001073030A2 Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073028A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
10/04/2001WO2001073027A2 Compositions and methods for therapy and diagnosis of colon cancer
10/04/2001WO2001073026A2 43238, a novel g protein-coupled receptor and uses therefor
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073024A1 Neurotrophic factor expression-inducing agent
1 ... 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 ... 2916